FDA boosts transparency to 77%

The FDA's mighty efforts to become a more transparent government agency, beginning with a transparency task force, convened in June, are yielding results, says blogger Mark Senak. His transparency metric of advisory committee rosters that include links to committee member CVs has seen a rise to 77 percent, up from 50 percent. Blog

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.